European scientific agreement on validation of animal testing alternatives

28 April 2009

Global efforts to promote alternatives to testing on animals received a significant boost through the signing of a cooperation agreement by  international bodies, including the European Commission's Joint  Research Center tasked with the validation of different test methods.

The accord, which should give new impetus to the worldwide availability  of scientifically-proven alternatives to animal test methods, has been  signed by the European Center for the Validation of Alternative Methods,  which is part of the Commission's Joint Research Center, together with  its equivalent in the USA (ICCVAM), Japan (JACVAM) and Canada's  Environmental Health Science and Research Bureau.

European Commissioner for Science and Research Janez Potocnik emphasized  the positive impacts of scientific international cooperation, saying:  "reducing animal testing, both out of concern for animal welfare and  ethical issues, and protecting consumer safety, are two major objectives  of this international agreement. I expect that European, American,  Japanese and Canadian scientists working together will more rapidly  identify scientifically-sound alternative testing methods."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight